Navigation Links
Complete 3-Chip Camera System, International

ProductsComplete 3-Chip Camera System, International
Company SOLOS Endoscopy, Inc.
Item Complete 3-Chip Camera System, International
Features 
  • 3-Chip Camera System
  • For microscopic application.
  • 800+ lines of resolution
  • Color bar generator
  • Auto iris
  • Automatic gain control
  • White balance
  • User-friendly design
  • International
  • Camera Control Unit
  • Camera Head
  • 1/2" format CCD
    • Description The 3-Chip Camera System offers 800+ lines of resolution along with color bar generator, auto iris, automatic gain control, and white balance features in a user-friendly design.

    Complete 3-Chip Camera System, International (GS 9920-PAL) includes:
  • (GS 9923) Camera Control Unit (CCU) with video cables
  • (GS 9925) Camera head with 3 meter cable (10 ft.)(1/2" format CCD)


    • SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic solutions.

    At SOLOS, excellence is not an option.
    Info SOLOS Endoscopy, Inc.
    Customer Service: (800) 388-6445
    Web site: http://www.solosendoscopy.com

    Related medicine products :

    1. Complete MoisturePlus
    2. Complete brand Blink-N-Clean Lens Drops
    3. Troutman Punch Complete with 7- 9.0 mm piston and Teflon Block
    4. Trouan Punch Complete with 7- 9.0 mm piston and Teflon Block
    5. MEDPOR Complete Orbit Complex
    6. Direct Focusing Headlight Complete
    7. Halogen Headlight Complete
    8. LCS Complete Mobile-Bearing Knee System
    9. NexGen Complete Knee Solution Legacy Knee Posterior Stabilized (LPS)
    10. NexGen Complete Knee Solution Cruciate Retaining (CR)
    11. NexGen Complete Knee Solution (CRA)
    Poly stat Strep A is a lateral flow, one-step immunoassay for the rapid, qualitative detection of Group A Streptococcal antigen from throat swabs. The test is intended for use as an aid in the diagn
    ...he ProTime Microcoagulation System monitors warfar...ient self-testing. Enhancements include an easy-t...le and replaceable battery. Software updates incl... computer or be transmitted to a LIS or EMR databa...
    ...ince 1994 the CoaguChek System has been providing ...eeded most, at the point of care. , The CoaguChe... of patients self-testing when monitoring on Couma...m allows the user to obtain a result from a finger...
    ...he Instacup Multi-Drug Screen Panel is used for th...man urine. The Instacup Panel consists of a test c... test card is inserted and the sample sealed with ...ot necessary to remove the test card to read the r...
    Medicine Products:
    (Date:10/7/2008)...alth-related Questions for Tonight,s,Presidential ...- WebMD, the leading source of,health information,...ial,candidates, proposed health care policies, loc...t the candidates, stance on health insurance, medi... public health issues., The in-depth coverage is ...
    (Date:10/7/2008)...PRNewswire-USNewswire/ -- The Ohio Nurses,Associat...ced today its,final round of endorsed candidates f...o Senate:, SD 26 Karen Gillmor (R) Tiffin, Ohio ...(R) Grove City;, HD 28 Connie Pillich (D) Cincinn...These ONA-endorsed candidates for the Ohio General...
    (Date:10/7/2008)...wswire-USNewswire/ -- Kristi Yamaguchi, Olympic,Go... the Stars, has been,named chairperson for the 200...gn in an effort to help raise funds in support of ...e and promote lung health., The American Lung Ass...o conquer Tuberculosis. Today, the Lung Associatio...
    (Date:10/7/2008)...ar to more expensive whole-leg color ultrasound, ...lthDay News) -- An older, simpler test to look for...osis, or DVT -- is as effective as a newer, more e...searchers found that 2-point ultrasonography of th...trasound -- was as good at detecting DVT as the ne...
    Breaking Medicine News(10 mins):Health News:WebMD Highlights Presidential Candidates' Views on Health Care 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 3Health News:Kristi Yamaguchi Chairs American Lung Association Christmas Seals Campaign 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3
    ...he spread of the disease are clearly not working a...// on a global basis if the disease is to be conta...ups of sex workers and drug addicts. It is here t...ortance. Individuals the world over, both in devel...
    ...ted by Welcare World Health Systems, has been lau...bulatory health care service comprising of outpati.../ services had been recently inagurated in Knowle... Ambulatory Care Center is open from 8 am to 11 pm...
    ...cross the world, according to the Center for Socia...bin Room. About 4.4% of deaths are accounted for b.... Alcohol is also responsible for as many deaths a...aws have reportedly failed to take note of this fa...
    ...al and Experimental Research which has revealed th... result in lesser consumption//. It only contribut...ior liquor. Researchers believe across-the-board ...e intended effects on alcohol sales, and suggest '...
    Other Medicine News:Health News:Need of the Hour: Viable Strategies against AIDS 2Health News:State Of The Art Healthcare Facility Opened In 'New Dubai' by Welcare 2Health News:Price Of Alcohol Does Not Influence Consumption 2
    (Date:10/6/2008)... More than 60 percent of moderate to severe pati... percent achieved endoscopic remission at Week 10,...at the American College,of Gastroenterology (ACG) .../- UCB today presented data from a,la...provement in Crohn,s,disease (CD) with a biologic ...
    (Date:10/6/2008)... Improved Pharmacokinetic Characteristics of Naltr...erability in Clinical Trials -, PHOENIX, Oct. 6 /...c.,(Nasdaq: OREX ), a biopharmaceutical company f...al nervous system-related disorders, today present...(R) (naltrexone SR /,bupropion SR), successfully a...
    (Date:10/6/2008)... SEATTLE, Oct. 6 /- Dendr...nce call today, Monday, October 6, 2008 at 9:00 AM...rim analysis of its IMPACT,(IMmunotherapy for Pros...B),clinical trial of PROVENGE(R) (sipuleucel-T), t...otherapy for the treatment of advanced prostate,ca...
    (Date:10/6/2008)... Recent study revealed that drinking polyphenol-...ith changes in appetite, energy intake or body,wei...ar consumption of 100%,polyphenol-rich Concord gra...s not associated with changes in appetite and was ...ew data presented at the 49th Annual Meeting of,th...
    Breaking Medicine Technology:CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 2CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 3CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 4CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 6CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 7Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 2Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 3Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 4Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 5Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial 2Concord Grape Juice Has No Significant Impact on Body Weight 2Concord Grape Juice Has No Significant Impact on Body Weight 3New Source of Heart Stem Cells Found 22491 1New Source of Heart Stem Cells Found 22491 2RxPop com Wins 7th Annual Horizon Interactive Award 22487 1RxPop com Wins 7th Annual Horizon Interactive Award 22487 2Health and Beauty Come Full Circle 3A Chado En Brings Full Benefit of Japanese Green Tea to Spas 22483 1Health and Beauty Come Full Circle 3A Chado En Brings Full Benefit of Japanese Green Tea to Spas 22483 2Concuity Announces Partnership with Financial Healthcare Systems LLC 6148 1Concuity Announces Partnership with Financial Healthcare Systems LLC 6148 2Concuity Announces Partnership with Financial Healthcare Systems LLC 6148 3Concuity Announces Partnership with Financial Healthcare Systems LLC 6148 4
    ....J., April 19, 2007 /PRNewswire-FirstCall/ --,VioQ...opharmaceutical company focused on acquiring, deve...ds, announced data from its,preclinical studies of...r the treatment of solid and hematologic tumors.,P...April 2007,Annual Meeting of the American Associat...
    ...sitive Top-Line Phase III Results for,Keppra® ...n,Paediatric Patients from One Month to Less than ...2007 - UCB today announced,positive top-line resul...ti-centre, placebo-controlled study evaluating the...acetam) (20-50,mg/kg/day) as adjunctive therapy in...
    Other Medicine Technology:VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 2VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 3VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 4VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 5UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 2UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 3UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 4UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 5